BioPharm International
April 01, 2017
Downstream Processing
30
4
For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.
April 01, 2017
Analytical Best Practices
30
4
Chromatography modeling can enhance bioprocessing efficiencies.
April 01, 2017
Analytical Best Practices
30
4
FTIR can successfully measure key characteristics of therapeutic proteins in a single step.
April 01, 2017
Product Spotlight
30
4
The Cannabis Analyzer for Potency from Shimadzu Scientific Instruments (SSI) is a high-performance liquid chromatograph (HPLC) specifically for quantitative determination of cannabinoid content.
April 01, 2017
Product Spotlight
30
4
The Thinky PR-1 Nanoparticle Dispersion Machine from Intertronics is a desktop unit that can disperse carbon nanotubes (CNT), graphene, and other 2D nanomaterials within a closed container.
April 01, 2017
Product Spotlight
30
4
The Quantum Pump from Watson Marlow Fluid Technology Group is a peristaltic pump with patented ReNu single-use (SU) cartridge technology.
April 01, 2017
Product Spotlight
30
4
The X500B QTOF System is the latest solution in SCIEX’s X-Series Quadrupole Time of Flight (QTOF) mass spectrometry (MS) platform.
April 01, 2017
Features
30
4
The author discusses the impact of prefilled syringe product contact materials and the filling and stoppering process on protein aggregates.
April 01, 2017
Upstream Processing
30
4
OrlaSURF technology can be used for the development of target-binding assays to monitor the binding of an ADC to its antigen.
April 01, 2017
Features
30
4
As regulators strive for balance in cGMPs for cell, gene, and tissue therapies, risk-management principles must guide decisions involving process media and additives.
April 01, 2017
Ask the Expert
30
4
Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the value of internal audits and how the information gained can be applied.
April 01, 2017
Perspectives on Outsourcing
30
4
New study shows China biopharma companies face staffing shortages.
April 01, 2017
Regulatory Beat
30
4
Industry fears limited benefits as FDA readies voluntary data tracking program.
April 01, 2017
Features
30
4
The complex nature of biologics adds additional CQAs that must be determined to ensure the safe development of biologics
April 01, 2017
Cover Story
30
4
Including next-gen antibodies in pharma pipelines is considered essential for future success.
April 01, 2017
Features
30
4
Understanding the purpose of the biological indicator can guide the development of an effective sterilization process.
April 01, 2017
Issue PDF
30
4
Click the title above to open the BioPharm International April 2017 issue in an interactive PDF format.